The simple moving average for the past 20 days is -10.07% for MAZE’s stock, with a -10.07% simple moving average for the past 200 days.
Is It Worth Investing in Maze Therapeutics Inc (NASDAQ: MAZE) Right Now?
MAZE currently public float of 24.03M.The average trading volume of MAZE on February 05, 2025 was 1.08M shares.
MAZE) stock’s latest price update
Maze Therapeutics Inc (NASDAQ: MAZE)’s stock price has gone decline by -11.67 in comparison to its previous close of 15.00, seekingalpha.com reported 2025-02-01 that Five IPOs listed this week, all of which raised over $100 million; one direct listing and three SPACs also debuted. Four microcaps submitted initial filings this week – Vistek, Awaysis Capital, QMSK Technology, and TV Channels Network. Two IPOs are currently scheduled for the week ahead, and a few more sizable names are eligible to launch.
MAZE Trading at -10.07% from the 50-Day Moving Average
After a stumble in the market that brought MAZE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -22.06% of loss for the given period.
During the last 5 trading sessions, MAZE fell by -16.93%, in comparison to the 20-day moving average. In addition, Maze Therapeutics Inc saw -16.93% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for MAZE
The liquidity ratio also appears to be rather interesting for investors as it stands at 8.77.
Conclusion
In summary, Maze Therapeutics Inc (MAZE) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
